114 related articles for article (PubMed ID: 16274927)
1. Tumor necrosis factor alpha inhibits aclacinomycin A-induced erythroid differentiation of K562 cells via GATA-1.
Morceau F; Schnekenburger M; Blasius R; Buck I; Dicato M; Diederich M
Cancer Lett; 2006 Aug; 240(2):203-12. PubMed ID: 16274927
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M
Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional and posttranscriptional regulation of erythroid gene expression in anthracycline-induced differentiation of human erythroleukemic cells.
Morceau F; Chénais B; Gillet R; Jardillier JC; Jeannesson P; Trentesaux C
Cell Growth Differ; 1996 Aug; 7(8):1023-9. PubMed ID: 8853898
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of gamma-globin mRNA and induction of irreversible erythroid differentiation after treatment of CML cell line K562 with new doxorubicin derivatives.
Szulawska A; Arkusinska J; Czyz M
Biochem Pharmacol; 2007 Jan; 73(2):175-84. PubMed ID: 17097070
[TBL] [Abstract][Full Text] [Related]
5. The benzophenanthridine alkaloid fagaronine induces erythroleukemic cell differentiation by gene activation.
Dupont C; Couillerot E; Gillet R; Caron C; Zeches-Hanrot M; Riou JF; Trentesaux C
Planta Med; 2005 Jun; 71(6):489-94. PubMed ID: 15971117
[TBL] [Abstract][Full Text] [Related]
6. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
Yi ZC; Wang Z; Li HX; Liu MJ; Wu RC; Wang XH
Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215
[TBL] [Abstract][Full Text] [Related]
7. The inhibitory effect of the proinflammatory cytokine TNFalpha on erythroid differentiation involves erythroid transcription factor modulation.
Buck I; Morceau F; Cristofanon S; Reuter S; Dicato M; Diederich M
Int J Oncol; 2009 Mar; 34(3):853-60. PubMed ID: 19212691
[TBL] [Abstract][Full Text] [Related]
8. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells.
Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S
Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of GATA-1 and NFE-2 erythroid-specific transcription factors during aclacinomycin-mediated differentiation of human erythroleukemic cells.
Trentesaux C; Nyoung MN; Aries A; Morceau F; Ronchi A; Ottolenghi S; Jardillier JC; Jeannesson P
Leukemia; 1993 Mar; 7(3):452-7. PubMed ID: 8445949
[TBL] [Abstract][Full Text] [Related]
10. A novel erythroid differentiation related gene EDRF1 upregulating globin gene expression in HEL cells.
Wang D; Li Y; Shen B
Chin Med J (Engl); 2002 Nov; 115(11):1701-5. PubMed ID: 12609092
[TBL] [Abstract][Full Text] [Related]
11. [A novel erythroid differentiation related gene EDRF1 upreguated globin gene expression in HEL cells].
Wang D; Shen B; Li Y
Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1512-5. PubMed ID: 16200778
[TBL] [Abstract][Full Text] [Related]
12. mNotch1 signaling and erythropoietin cooperate in erythroid differentiation of multipotent progenitor cells and upregulate beta-globin.
Henning K; Schroeder T; Schwanbeck R; Rieber N; Bresnick EH; Just U
Exp Hematol; 2007 Sep; 35(9):1321-32. PubMed ID: 17637499
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor α-mediated inhibition of erythropoiesis involves GATA-1/GATA-2 balance impairment and PU.1 over-expression.
Grigorakaki C; Morceau F; Chateauvieux S; Dicato M; Diederich M
Biochem Pharmacol; 2011 Jul; 82(2):156-66. PubMed ID: 21501595
[TBL] [Abstract][Full Text] [Related]
14. Increased glutathione S-transferase P1-1 expression by mRNA stabilization in hemin-induced differentiation of K562 cells.
Schnekenburger M; Morceau F; Duvoix A; Delhalle S; Trentesaux C; Dicato M; Diederich M
Biochem Pharmacol; 2004 Sep; 68(6):1269-77. PubMed ID: 15313425
[TBL] [Abstract][Full Text] [Related]
15. Evidence for distinct regulation processes in the aclacinomycin- and doxorubicin-mediated differentiation of human erythroleukemic cells.
Morceau F; Aries A; Lahlil R; Devy L; Jardillier JC; Jeannesson P; Trentesaux C
Biochem Pharmacol; 1996 Mar; 51(6):839-45. PubMed ID: 8602880
[TBL] [Abstract][Full Text] [Related]
16. Chemokine expression in human erythroid leukemia cell line AS-E2: macrophage inflammatory protein-3alpha/CCL20 is induced by inflammatory cytokines.
Inoue Y; Tsushima H; Ando K; Sawayama Y; Sakai M; Yamasaki R; Matsuo E; Tsutsumi C; Imaizumi Y; Iwanaga M; Imanishi D; Taguchi J; Miyazaki Y; Tomonaga M
Exp Hematol; 2006 Jan; 34(1):19-26. PubMed ID: 16413387
[TBL] [Abstract][Full Text] [Related]
17. Activation of erythroid-specific promoters during anthracycline-induced differentiation of K562 cells.
Aries A; Trentesaux C; Ottolenghi S; Jardillier JC; Jeannesson P; Doubeikovski A
Blood; 1996 Apr; 87(7):2885-90. PubMed ID: 8639908
[TBL] [Abstract][Full Text] [Related]
18. Murine erythropoietic impairment induced by paclitaxel: interactions of GATA-1 and erythroid Krüppel-like transcription factors, apoptotic related proteins and erythropoietin receptor.
Aguirre MV; Todaro JS; Juaristi JA; Brandan NC
Eur J Pharmacol; 2010 Jun; 636(1-3):42-51. PubMed ID: 20353770
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Sp1/Sp3 in the activation of the GATA-1 erythroid promoter in K562 cells.
Hou CH; Huang J; He QY; Zhang CN; Zhang XJ; Qian RL
Cell Res; 2008 Feb; 18(2):302-10. PubMed ID: 18195733
[TBL] [Abstract][Full Text] [Related]
20. Anthracyclines as tumor cell differentiating agents: effects on the regulation of erythroid gene expression.
Jeannesson P; Lahlil R; Chenais B; Devy L; Gillet R; Aries A; Morceau F; Trentesaux C
Leuk Lymphoma; 1997 Aug; 26(5-6):575-87. PubMed ID: 9389364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
